Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of…
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.
Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said…
CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill Foundayo
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
The Deadly Venom Behind Ozempic—and Why the Miracle Drug Should Have Never Worked
When scientists first discovered the insulin secretion effects of gut hormone GLP-1 in the 1980s, it seemed like…
Scientists Discover Common Medications May Secretly Alter Your Gut for Years
Researchers found that many commonly prescribed drugs, not just antibiotics, were linked to long-lasting microbial changes that could…
What medicine-exposed rats reveal about the next urban zoonotic threat
A new study reveals that urban rats are absorbing human medicines from polluted environments, and these hidden pharmaceutical…
Eli Lilly weight loss drug retatrutide clears obesity trial
Eli Lilly on Thursday said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering…
Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…
When pills change shapes and colors, confusion is a side effect
At the ripe old age of 73, I take six drugs — four prescription and two over-the-counter pills…
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…
Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development
MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…